Contact Us

Defective Drugs
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

   * Phone 

Cell Phone 

Name of drug: 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Parker Waichman LLP Headlines by Topic

Xenical

Europe Regulators Launch New Orlistat Review

Sep 26, 2011
| Parker Waichman LLP
European regulators have launched a safety review of the orlistat-containing medications, Alli and Xenical, following more reports of liver problems...

Alli, Xenical Get Warnings For Severe Liver Injury

May 27, 2010
| Parker Waichman LLP
The safety labels for Xenical, and its over-the-counter counterpart, Alli, are being modified to include information about potential rare occurrences...

Glaxo Defends Alli Safety Record

Sep 14, 2009
| Parker Waichman LLP
Last month we wrote that the U.S. Food & Drug Administration (FDA) was conducting a safety review of orlistat, the popular weight-loss drug sold...

Page 1/1